The Current Ratio as of November 2024 (TTM) for Benitec Biopharma Inc. (BNTC) is 10.49

According to Benitec Biopharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.49. This represents a change of 74.04% compared to the average of 6.03 of the last 4 quarters.

Benitec Biopharma Inc. (BNTC) Historical Current Ratio (quarterly & annually)

How has BNTC Current Ratio performed in the past?

The mean historical Current Ratio of Benitec Biopharma Inc. over the last ten years is 10.69. The current 10.49 Current Ratio has changed 9.72% with respect to the historical average. Over the past ten years (40 quarters), BNTC's Current Ratio was at its highest in in the December 2014 quarter at 41.62. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Benitec Biopharma Inc. (BNTC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Benitec Biopharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Benitec Biopharma Inc. (BNTC) Average Current Ratio

How has BNTC Current Ratio performed in the past?

The current Current Ratio of Benitec Biopharma Inc. (BNTC) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Benitec Biopharma Inc. (BNTC) Current Ratio vs. Peers

How is BNTC’s Current Ratio compared to its peers?

Benitec Biopharma Inc.’s Current Ratio is greater than Bio-Path Holdings, Inc. (1.67), greater than Catalyst Biosciences, Inc. (0), less than Diffusion Pharmaceuticals Inc. (10.96), greater than Capricor Therapeutics, Inc. (1.37), greater than NextCure, Inc. (8.35), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than Landos Biopharma, Inc. (4.43), greater than Apexigen, Inc. (0.82), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Angion Biomedica Corp. (1.74), greater than Applied Molecular Transport Inc. (4.99), greater than Aileron Therapeutics, Inc. (4.69), greater than Virios Therapeutics, Inc. (7.27), less than Zura Bio Limited (12.57), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Oncorus, Inc. (1.50), greater than Apollomics, Inc. (2.25), greater than Sigilon Therapeutics, Inc. (1.78),

Build a custom stock screener for Benitec Biopharma Inc. (BNTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Benitec Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Benitec Biopharma Inc. (BNTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Benitec Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.